Overview of resistant hypertension:A glimpse of the cardiologist's current standpoint

被引:0
作者
Luis Paiva [1 ]
Maria Carmo Cachulo [1 ]
Rui Providencia [1 ]
Sergio Barra [1 ]
Paulo Dinis [1 ]
Antonio Leitao-Marques [1 ]
机构
[1] Cardiology Department,Coimbra’s Hospital and University Centre,3041-801 Coimbra,Portugal
关键词
Hypertension; Resistant hypertension; Management;
D O I
暂无
中图分类号
R544.1 [高血压];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is a major risk factor for cardiovascular disease,resulting in increased incidence of cerebrovascular events,ischaemic heart disease,heart failure,and renal impairment.Thus,it is one of the most important preventable causes of premature morbidity and mortality.Despite current knowledge on the management of hypertension and the availability of several effective antihypertensive medications,uncontrolled hypertension remains a common and challenging clinical problem.Resistant hypertension is a complex condition with multiple contributing factors and overlapping comorbidities.Although there is limited hard evidence regarding resistant hypertension,our understanding of this condition has improved recently.This article will present an overview of resistant hypertension and highlight recent publications about this topic.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 20 条
[1]   Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension [J].
Brandt, Mathias C. ;
Mahfoud, Felix ;
Reda, Sara ;
Schirmer, Stephan H. ;
Erdmann, Erland ;
Boehm, Michael ;
Hoppe, Uta C. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (10) :901-909
[2]   Description of Antihypertensive Use in Patients With Resistant Hypertension Prescribed Four or More Agents [J].
Hanselin, Michele R. ;
Saseen, Joseph J. ;
Allen, Richard R. ;
Marrs, Joel C. ;
Nair, Kavita V. .
HYPERTENSION, 2011, 58 (06) :1008-1013
[3]  
Renal Sympathetic Denervation: A Novel Intervention for Resistant Hypertension, Insulin Resistance, and Sleep Apnea[J] . Brent M. Egan. Hypertension . 2011 (4)
[4]  
Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension[J] . John D. Bisognano,George Bakris,Mitra K. Nadim,Luis Sanchez,Abraham A. Kroon,Jill Schafer,Peter W. de Leeuw,Domenic A. Sica. Journal of the American College of Cardiology . 2011 (7)
[5]  
Prevalence of Resistant Hypertension in the United States, 2003–2008[J] . Stephen D. Persell. Hypertension . 2011 (6)
[6]   Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring [J].
de la Sierra, Alejandro ;
Segura, Julian ;
Banegas, Jose R. ;
Gorostidi, Manuel ;
de la Cruz, Juan J. ;
Armario, Pedro ;
Oliveras, Anna ;
Ruilope, Luis M. .
HYPERTENSION, 2011, 57 (05) :898-U74
[7]  
Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin–angiotensin–aldosterone system[J] . Beatriz Alvarez-Alvarez,María Abad-Cardiel,Arturo Fernandez-Cruz,Nieves Martell-Claros. Journal of Hypertension . 2010 (11)
[8]  
Novel Baroreflex Activation Therapy in Resistant Hypertension[J] . Ingrid J.M. Scheffers,Abraham A. Kroon,Jürg Schmidli,Jens Jordan,Jan J.M. Tordoir,Markus G. Mohaupt,Friedrich C. Luft,Hermann Haller,Jan Menne,Stefan Engeli,Jiri Ceral,Siegfried Eckert,Andrejs Erglis,Krzysztof Narkiewicz,Thomas Philipp,Peter W. de Leeuw. Journal of the American College of Cardiology . 2010 (15)
[9]  
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial[J] . The Lancet . 2010 (9756)
[10]   Characterization and treatment of resistant hypertension [J].
Pisoni R. ;
Ahmed M.I. ;
Calhoun D.A. .
Current Cardiology Reports, 2009, 11 (6) :407-413